Following the completion of the mandatory public tender offer,
Novartis (www.novartis.com)
announced on September 25, 2008 that it holds 99.8% of the current
outstanding public shares in Speedel Holding Ltd. The
“squeeze-out” procedure for the remaining shareholders
is underway.
Operations are being transferred to Novartis, with a completion
date anticipated by the end 2008. Legal processes are foreseen
to be concluded in early 2009.
If you have any questions around the acquisition and integration
of Speedel into Novartis as well as the appropriate business contact
within Novartis please refer to:
Investor Relations:
Thomas Hungerbühler, Investor Relations Manager
Novartis International, Basel, Switzerland
thomas.hungerbuehler@novartis.com
Phone: +41 61 324 84 25 |
Media Relations:
Eric Althoff, Director Global Media Relations Novartis International, Basel, Switzerland
eric.althoff@novartis.com
Phone + 41 61 324 7999 |